Trading For This Specialty Pharma Company is up Following Second Quarter Results
10 Agosto 2023 - 10:00AM
AllPennyStocks.com
This stock is almost a penny stock no longer, as shares moved
close to the $5 threshold following the firm’s quarterly
announcement. Leading pan-American (ex-US) specialty pharmaceutical
firm...
To read the full story on AllPennyStocks.com, click
here.
Knight Therapeutics (TSX:GUD)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Knight Therapeutics (TSX:GUD)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
